Prednisolone in Breastfeeding
Prednisolone is safe and compatible with breastfeeding at all doses, and mothers can breastfeed immediately after taking their medication without waiting.
Safety Profile
The most recent and comprehensive 2025 Global Consensus Statement on IBD management provides robust evidence supporting prednisolone use during lactation 1. The data demonstrates:
- 124 women with transplants took prednisone while breastfeeding 169 infants for periods up to 48 months with no reported infant harm 1
- 34 additional case reports of infants breastfed during maternal therapy with up to 60 mg/day showed no adverse effects 1
- Even with maternal doses up to 120 mg/day, worst-case infant exposure remained less than 100 mg/day 1
Infant Exposure Levels
The infant receives minimal drug exposure:
- After a single 1-gram IV dose of prednisolone, the daily infant dose would be 0.32 mg/kg, which is only one-sixth of a therapeutic pediatric dosage of 2 mg/kg daily 1
- Both prednisone and prednisolone are excreted into milk, and infants can convert prednisone to prednisolone, making total drug concentration the relevant measure 1
- Research shows breast milk/plasma ratios of 0.5-0.6 for prednisone and 0.02-0.03 for prednisolone, with relative infant doses of 0.35-0.53% and 0.09-0.18% respectively 2
No Timing Restrictions Needed
Prior recommendations to wait 4 hours after dosing before breastfeeding with high maternal doses have been shown to be unnecessary in recent studies 1. This is a critical update from older guidance.
The 2007 EULAR guideline suggested waiting 4 hours to minimize exposure 3, but this has been superseded by more recent evidence showing this precaution is not required 1. The 2020 American College of Rheumatology guideline still recommends delaying breastfeeding 4 hours after doses ≥20 mg 4, but this conflicts with the most recent 2025 evidence showing no need for timing restrictions 1.
Dosing Considerations
All doses are compatible with breastfeeding:
- Low doses (<20 mg/day): Fully compatible with immediate breastfeeding 4, 5
- Moderate to high doses (20-120 mg/day): Also compatible with immediate breastfeeding based on the most recent 2025 evidence 1
- High-dose IV methylprednisolone pulses (1000 mg): Peak milk concentrations occur 1-2 hours after administration, but exposure remains minimal with RID of 0.50% 6
Clinical Monitoring
No special infant monitoring is required for standard prednisolone use during breastfeeding. The evidence shows:
- No increased infection rates in breastfed infants 1
- No growth or developmental concerns 1
- No adrenal suppression at typical maternal doses 1
Common Pitfalls to Avoid
- Don't unnecessarily discontinue breastfeeding - The benefits of breastfeeding outweigh minimal drug exposure
- Don't advise waiting 4 hours - This outdated recommendation has been disproven by recent studies 1
- Don't confuse prednisolone with methotrexate - Unlike methotrexate which requires caution, prednisolone has extensive safety data 1
- Don't switch from effective therapy - If a mother is controlled on prednisolone, continue it rather than switching to unfamiliar alternatives
Supporting Evidence Quality
The 2025 Global Consensus Statement 1 represents the highest quality and most recent guideline evidence, published in Clinical Gastroenterology and Hepatology. This supersedes older recommendations and is based on:
- Large registry data (National Transplantation Pregnancy Registry)
- Multiple case series totaling >200 mother-infant pairs
- Pharmacokinetic studies measuring actual drug transfer 2
- Long-term follow-up data (up to 48 months) 1
The FDA label 7 advises caution but does not contraindicate breastfeeding, stating that systemically administered corticosteroids appear in human milk and recommending careful consideration - this is appropriately conservative but less specific than the clinical guideline evidence.